Opendata, web and dolomites

SERAS_v4.0 SIGNED

Seizure Risk Asessment for Epilepsy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SERAS_v4.0 project word cloud

Explore the words cloud of the SERAS_v4.0 project. It provides you a very rough idea of what is the project "SERAS_v4.0" about.

neurological    quality    million    seras    monitor    permanently    source    artificial    consists    commercialization    sme    vision    functionalities    usa    knowing    seizure    containing    benchmark    patient    health    electroencephalogram    people    data    medical    global    generation    social    invasive    claim    signals    everybody    patients    clinically    neuroserveis    caused    65    care    instrument    learning    discrete    doctors    pathologies    treatments    2025    earpiece    seizures    frequency    alerts    brain    suffers    prediction    mobile    intelligence    portable    intensity    business    mjn    accelerate    platform    digital    suffer    occurs    services    moved    validated    wearable    device    diseases    disruptive    suffered    time    accident    monitoring    continuous    predicting    connected    monitors    epilepsy    life    world    worldwide    turnover    cloud    create    reads    automate    epileptic    reports    market    serious    depending    27    solution    algorithm    predicts    recorded    plan    minute    ph2    permanent    live    environment    accidents   

Project "SERAS_v4.0" data sheet

The following table provides information about the project.

Coordinator
MJN NEUROSERVEIS SL 

Organization address
address: AVENUE JOAN CARLES 184 PLANTA BJS PUERTA DR
city: BLANES
postcode: 17300
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 2˙568˙300 €
 EC max contribution 1˙797˙810 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-04-01   to  2021-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MJN NEUROSERVEIS SL ES (BLANES) coordinator 1˙797˙810.00

Map

 Project objective

MJN Neuroserveis’ has developed SERAS, a non-invasive, discrete and wearable device that predicts an epileptic seizure before it occurs. The device consists of an earpiece that reads the electroencephalogram, and a cloud-connected mobile application containing an artificial intelligence algorithm that alerts the user, their environment, and medical services one minute before a seizure occurs. In addition, the device permanently monitors a patient's brain activity, allowing for the generation of medical reports, the number of seizures suffered, their intensity and frequency. Currently, doctors who care for these patients do not have the data to allow for targeted patient treatments. Today, there is no device clinically validated in the market with these functionalities that can permanently monitor brain activity in a discrete, portable and continuous way. Around 50-65 million people suffers from epilepsy worldwide, depending on source. These people live in a permanent state of uncertainty, caused by not knowing when they will suffer the next seizure and if it could cause a serious accident for them. SERAS is a disruptive solution unique in monitoring brain signals and predicting epilepsy seizures with enough time to avoid accidents. MJN is a business moved by high social impact vision; our claim is ‘Quality of life for everybody’. We face a market of 6 million epileptic people in EU and USA. We aim to become a new benchmark on a global scale in the digital health world related with neurological diseases. SME Instrument Ph2 project will help us to improve our prediction algorithm in order to automate learning process and create a platform to exploit data recorded from users of the device. This will allow us and doctors go a step further on research of neurological pathologies. By Ph2 project we will accelerate our commercialization plan to scale-up our business to the goal of €27 million turnover by 2025.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SERAS_V4.0" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SERAS_V4.0" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

Genetta (2019)

Pole climbing solution to improve safety at work and to prevent fatal accidents in industrial climbing

Read More  

CyreenApplication (2019)

Connecting Ad-Impressions with Purchase. The new advanced Advertisement at the point of sales.

Read More